Related Experiment Video
Updated: Jun 1, 2026

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
IGF1R signaling in Ewing sarcoma is shaped by clathrin-/caveolin-dependent endocytosis
Ana Sofia Martins1, José Luis Ordóñez, Ana Teresa Amaral
1Laboratory 20-Molecular Pathology of Sarcomas Laboratory, Centro de Investigación del Cáncer-IBMCC, Universidad de Salamanca-CSIC, Salamanca, Spain.
Abstract:
Receptor endocytosis is critical for cell signaling. IGF1R mediates an autocrine loop that is de-regulated in Ewing Sarcoma (ES) cells. Here we study the impact of IGF1R internalization, mediated by clathrin and caveolin-1 (CAV1), in ES signaling. We used clathrin and CAV1-siRNA to interfere in clathrin- and caveolin-dependent endocytosis. Chlorpromazine (CPMZ) and methyl-beta-cyclo-dextrin (MCD) were also used in order to inhibit clathrin- and caveolin-dependent endocytosis, respectively. We analyzed IGF1R internalization and co-localization with clathrin and CAV1 upon ligand binding, as well as the status of the IGF1R pathway, cellular proliferation, and the apoptosis of interfered and inhibited ES cells. We performed a high-throughput tyrosine kinase phosphorylation assay to analyze the effects of combining the IGF1R tyrosine kinase inhibitor AEW541 (AEW) with CPMZ or MCD on the intracellular phospho-proteome. We observed that IGF1R is internalized upon ligand binding in ES cells and that this process is dependent on clathrin or CAV1. The blockage of receptor internalization inhibited AKT and MAPK phosphorylation, reducing the proliferative rate of ES cells and increasing the levels of apoptosis. Combination of AEW with CPMZ or MCD largely enhanced these effects. CAV1 and clathrin endocytosis controls IGF1R internalization and signaling and has a profound impact on ES IGF1R-promoted survival signaling. We propose the combination of tyrosine-kinase inhibitors with endocytosis inhibitors as a new therapeutic approach to achieve a stronger degree of receptor inhibition in this, or other neoplasms dependent on IGF1R signaling.
Insights
Inhibiting Insulin-like Growth Factor 1 Receptor (IGF1R) internalization via clathrin or caveolin-1 (CAV1) pathways reduces Ewing Sarcoma cell growth and increases apoptosis. Combining IGF1R inhibitors with endocytosis blockers enhances these anti-cancer effects.
Area of Science:
- Cell Biology
- Molecular Oncology
- Cancer Signaling
Background:
- Receptor endocytosis is crucial for cellular signaling pathways.
- The Insulin-like Growth Factor 1 Receptor (IGF1R) plays a key role in Ewing Sarcoma (ES) cell survival through an autocrine loop.
- IGF1R internalization, mediated by clathrin and caveolin-1 (CAV1), is implicated in ES signaling.
Purpose of the Study:
- To investigate the impact of IGF1R internalization, dependent on clathrin and CAV1, on Ewing Sarcoma signaling.
- To evaluate the effects of inhibiting IGF1R endocytosis on ES cell proliferation and apoptosis.
- To explore the potential of combining IGF1R inhibitors with endocytosis inhibitors as a therapeutic strategy.
Main Methods:
- Utilized clathrin and CAV1-siRNA to disrupt clathrin- and caveolin-dependent endocytosis.
- Employed chlorpromazine (CPMZ) and methyl-beta-cyclo-dextrin (MCD) to inhibit clathrin- and caveolin-dependent endocytosis, respectively.
- Analyzed IGF1R internalization, co-localization with clathrin/CAV1, signaling pathway status (AKT, MAPK), proliferation, and apoptosis. Performed high-throughput tyrosine kinase phosphorylation assays.
Main Results:
- IGF1R internalization in ES cells upon ligand binding was confirmed to be dependent on clathrin or CAV1.
- Blocking IGF1R internalization significantly inhibited AKT and MAPK phosphorylation, reduced cellular proliferation, and increased apoptosis.
- Combining the IGF1R inhibitor AEW541 (AEW) with CPMZ or MCD markedly enhanced these inhibitory effects.
Conclusions:
- Clathrin and CAV1-mediated endocytosis critically control IGF1R internalization and downstream signaling in Ewing Sarcoma.
- Inhibition of IGF1R internalization profoundly impacts ES cell survival signaling.
- The combination of tyrosine-kinase inhibitors with endocytosis inhibitors presents a promising therapeutic approach for neoplasms reliant on IGF1R signaling.
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Intracellular Signaling Affects Focal Adhesions
Some...
Mitogens and the Cell Cycle
Regulation of Angiogenesis and Blood Supply
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...

